Purpose: The vitamin E compound α-tocopherol inhibits fibroblast growth in vitro. To evaluate its potential benefit in preventing failure of glaucoma filtration surgery, we prospectively investigated the outcome of filtering surgery with postoperative dietary α-tocopherol supplementation. Patients and Methods: Thirty-nine patients (39 eyes) with primary open-angle glaucoma or pseudoexfoliative glaucoma were randomly assigned to two post-(phaco)-trabeculectomy treatment groups. Daily oral intake of 300 mg α-tocopheryl-acetate (absorbed as α-tocopherol in the intestine) for 2 months was compared to a placebo preparation in a double-blind trial. The follow-up time was 1 year. Success was defined as intraocular pressure (IOP) ≤18 mm Hg with no medication, no needling revision, and no subconjunctival injection. Results: In the tocopherol group, the relative risk for trabeculectomy failure decreased from 1.58 at 2 weeks (p = 0.95) to 1.0 at 1 year. Success rates (67–90%) and IOP reduction (mean 39 to 53%) were statistically comparable in the two groups. Considering postoperative complications, no relevant differences were found. Discussion: Trabeculectomy and phacotrabeculectomy outcome did not show any differences between α-tocopherol-supplemented patients and the placebo group.

1.
Larrosa JM, Polo V, Ramirez T, et al: α-Tocopherol derivatives and wound healing in an experimental model of filtering surgery. Ophthalmic Surg Lasers 2000;31:131–135.
2.
Larrosa Poves JM, Polo Llorens V, Ramírez Gasca T, Pinilla Lozano I, Pablo Júlvez LE, Cuevas Andrés R, Rojo Aragües A, Honrubia López FM: Histopathological evaluation of vitamin E derivatives effects on the healing process of a model of filtration surgery Arch Soc Esp Oftalmol 2000;75:523–528.
3.
Pinilla I, Larrosa JM, Polo V, et al: α-Tocopherol derivatives in an experimental model of filtering surgery. Ophthalmic Res 1999;31:440–445.
4.
Pinilla I, Piazuelo E, Jimenez P, et al: Inhibitory effect of α-tocopherol succinate on fibroblast wound healing. Arch Soc Esp Oftalmol 2000;75:383–388.
5.
Haas AL, Boscoboinik D, Mojon DS, et al: Vitamin E inhibits proliferation of human Tenon’s capsule fibroblasts in vitro. Ophthalmic Res 1996;28:171–175.
6.
Meyenberg A, Goldblum D, Zingg JM, et al: Tocotrienol inhibits proliferation of human Tenon’s fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C. Graefes Arch Clin Exp Ophthalmol 2005;243:1263–1271.
7.
Chang MR, Cheng Q, Lee DA: Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther 1998;14:75–95.
8.
Wilkins M, Indar A, Wormald R: Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2005;4:CD002897.
9.
Wormald R, Wilkins MR, Bunce C: Post-operative 5-fluorouracil for glaucoma surgery. Cochrane Database Syst Rev 2001;3:CD001132.
10.
Singh J, O’Brien C, Chawla HB: Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye 1995;9:460–466.
11.
Higginbotham EJ, Stevens RK, Musch DC, et al: Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650–656.
12.
DeBry PW, Perkins TW, Heatley G, et al: Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002;120:297– 300.
13.
Fuller JR, Bevin TH, Molteno AC, et al: Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long-term control of intraocular pressure without risk of sight threatening complications. Br J Ophthalmol 2002;86:1352–1354.
14.
Mickle DA, Weisel RD, Burton GW, et al: Effect of orally administered α-tocopherol acetate on human myocardial α-tocopherol levels. Cardiovasc Drugs Ther 1991;5:309–312.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.